2020年8月28日 · Milrinone is a medication indicated for cardiac support in patients with acute heart failure, pulmonary hypertension, or chronic heart failure. It improves cardiac contractility (inotropy) and cardiac relaxation (lusitropy) and induces vasodilation.

2024年4月3日 · What is milrinone? Milrinone is a vasodilator that is used as a short-term treatment for life-threatening heart failure. Milrinone may also be used for purposes not listed in this medication guide.

Milrinone, sold under the brand name Primacor, is a pulmonary vasodilator [2] used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance.

MILRINONE (MILL rih none) is an inotrope and vasodilator. It increases the strength of the heart muscle and widens blood vessels. It is used to treat heart failure.

Milrinone is a PDE-III inhibitor with inotropic, lusitropic, and vasodilatory properties used for the short-term treatment of acute decompensated heart failure. Heart failure is a multifactorial condition that affects roughly 1-2% of the adult population.

Find patient medical information for milrinone intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

2020年2月17日 · Includes Milrinone indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.

Find patient medical information for milrinone in 5 % dextrose intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

2025年1月23日 · Milrinone package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Milrinone is a medication used to manage severe heart conditions, such as heart failure and cardiogenic shock. It works by helping the heart pump more effectively, which improves blood flow throughout the body. Milrinone is typically administered intravenously (IV) in a hospital setting.